Nuvation Bio

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$727
$1,435
$264
$264
Gross Profit
-788
-156
-58
209
EBITDA
-41,090
-462,116
-20,141
-20,776
EBIT
-41,252
-462,360
-20,199
-20,819
Net Income
-41,210
-462,492
-14,792
-13,787
Net Change In Cash
727
1,435
264
264
Free Cash Flow
53,053
-37,324
-15,729
-15,042
Cash
30,036
34,285
34,510
42,649
Basic Shares
273,565
244,738
219,048
218,993

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-222
-484
-368
-103
EBITDA
-99,600
-119,535
-89,347
-43,448
EBIT
-99,822
-120,019
-89,715
-43,551
Net Income
-75,802
-88,664
-79,734
-39,496
Net Change In Cash
0
0
0
0
Cost of Revenue
-31,324
102,668
Free Cash Flow
-68,068
-96,478
-68,472
-36,674
Cash
42,649
101,099
132,423
29,755
Basic Shares
218,880
216,721
197,887
97,530

Earnings Calls

Quarter EPS
2024-09-30
-$0.15
2024-06-30
-$0.15
2024-03-31
-$0.07
2023-12-31
-$0.06